iiinova — where your digital self keeps evolving

Barbara Hernando @bhernando.bsky.social · 12/09/2026

1/ NEW PAPER 🎉 🧵 We mapped the mutational processes shaping 959 prostate cancer genomes from the Pan Prostate Cancer Group (PPCG), integrating SBS, ID, CX and complex SV signatures. Eight footprints account for the processes in 85% of cases www.nature.com/articles/s41... @nature.com

nature.com

Integrated signatures define mutational processes in prostate cancer - Nature

Eight integrated mutational footprints collectively explain the mutational processes in 85% of primary prostate cancer genomes.

154

Barbara Hernando @bhernando.bsky.social · 10/08/2026

Check it now! 💫 Exited to share this preprint, the result of a fantastic collaboration between Sarah Aitken’s and Martin Taylor’s labs. During my secondment at @yalecancer.bsky.social @yalepathology.bsky.social, I contributed to explore how H&E images can be used to predict tumour genomics

043

Reposted by Barbara Hernando

Sarah Aitken @s-j-aitken.bsky.social · 27/07/2026

🧬NEW PAPER🧬 To what extent is cancer development deterministic? Does the germline genome affect that predictability? Find out in our #StrainDifferences paper @nature.com "Genetic background sets the trajectory of experimental cancer evolution" www.nature.com/articles/s41... 🧵[1/14]

nature.com

Genetic background sets the trajectory of experimental cancer evolution - Nature

Experimentally replaying tumour evolution in divergent mouse strains reveals the importance of interactions between genetic ancestry and acquired cancer-driving mutations in shaping the earliest stage...

14717

Barbara Hernando @bhernando.bsky.social · 19/12/2025

Thanks for everything! I will miss being around in the lab but see you online 🫶🏻

021

Barbara Hernando @bhernando.bsky.social · 04/12/2025

Had a lovely dinner today with members of @s-j-aitken.bsky.social’s lab to celebrate my recent preprint! Sharing these small milestones (and the joy that comes with them) with friends is just magic ✨

130

Barbara Hernando @bhernando.bsky.social · 30/10/2025

It was an honor to take part in the @yalepathology.bsky.social research retreat today! Great science, inspiring discussions, a fun “guess who?”, and wonderful people. Huge thanks to organizers for such a great work! Can’t believe only 2 months left to enjoy this amazing #AitkenLab team ✨

011

Reposted by Barbara Hernando

Sarah Aitken @s-j-aitken.bsky.social · 10/10/2025

A trio of talks this week: Grand Rounds @jhu.edu yesterday. Then @bhernando.bsky.social (who has only been here a fortnight!) and I gave talks at the NYC Genome Integrity Discussion group @rockefeller.edu. Thanks for inviting us Agata Smogorzewska and Philipp Oberdoerffer @yalepathology.bsky.social

092

Barbara Hernando @bhernando.bsky.social · 29/09/2025

Exciting 3 months ahead at the #AitkenLab @yaleschoolofmed.bsky.social! 🤩 Huge thanks to @s-j-aitken.bsky.social for the warm welcome, and to @caixaresearch.bsky.social for supporting my research career at all levels ✨

051

Reposted by Barbara Hernando

cniostopcancer.bsky.social @cniostopcancer.bsky.social · 23/06/2025

#CNIOStopCancer develop test that predicts which patients will not respond to cancer chemotherapy. They have identified biomarkers which, in clinical practice, would allow for more effective treatments and the avoidance of side effects. bit.ly/465QqnR

111

Reposted by Barbara Hernando

cniostopcancer.bsky.social @cniostopcancer.bsky.social · 23/06/2025

Un estudio del #CNIOStopCancer descubre biomarcadores que predicen qué pacientes no responderán a la quimioterapia contra el cáncer. Podrían servir para descartar tratamientos que no van a funcionar, pero provocan efectos secundarios y son caros. bit.ly/4lj1QJn

111

Reposted by Barbara Hernando

Geoff Macintyre @gmaci.bsky.social · 23/06/2025

🚨Chemo treatment upgrade!🚨 Check out our approach to modernise chemotherapy treatment published today in @natgenet.nature.com. From @cniostopcancer.bsky.social #TailorBio @cruk-ci.bsky.social www.nature.com/articles/s41... More details 👇

nature.com

1179

Barbara Hernando @bhernando.bsky.social · 10/06/2025

💥New preprint from the @gmaci.bsky.social lab! Thrilled to share this major team effort, with #Angel as co-first author, now live on bioRxiv! Check out our threat to learn more about our work👇

010

Barbara Hernando @bhernando.bsky.social · 14/05/2025

Flying back from Bologna after the Pan Prostate Cancer Group #PPCG meeting. 3 days of fruitful discussions with lovely colleagues at the best venue I have ever been 🤩

030

Barbara Hernando @bhernando.bsky.social · 27/04/2025

Day 1 at #AACR2025 from my side! Meanwhile, at the #EMBO workshop on Chromosome Segregation and Aneuploidy, Maria Escobar will be presenting our project on ongoing CIN in KRAS mutant pancreatic organoids! A must meeting for the #CIN community meetings.embo.org/event/25-ane...

meetings.embo.org

Chromosome Segregation and Aneuploidy

Aneuploidy is a hallmark of cancer and developmental disorders such as Down syndrome. Understanding how cells accomplish faithful chromosome segregation and how chromosomal instability (CIN) impacts …

031

Barbara Hernando @bhernando.bsky.social · 26/04/2025

Ready for #AACR25! Excited for five full days of talks, posters and educational sessions in cancer research, and also for catching up with colleagues and friends 🤩

080